AbbVie (ABBV) Price to Book (2012 - 2026)

AbbVie (ABBV) has reported Price to Book for 15 consecutive years, with 74.92 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book rose 96.85% year-over-year to 74.92 in Q2 2026; TTM through Jun 2026 was 74.92, a 96.85% increase from a year earlier, with the FY2025 full-year figure at 123.55, down 232.49% from the prior year.
• Price to Book was 74.92 for Q2 2026 at AbbVie, down from 58.12 in the prior quarter.
• Over five years, Price to Book peaked at 253.14 in Q1 2025 and troughed at 2376.15 in Q2 2025.
• A 5-year average of 119.13 and a median of 18.44 in 2022 frame the typical range for Price to Book.
• The widest YoY moves for Price to Book: up 533.48% in 2025, down 5449.73% in 2025.
• Over 5 years, Price to Book stood at 16.54 in 2022, then soared by 59.17% to 26.33 in 2023, then jumped by 254.17% to 93.25 in 2024, then tumbled by 232.49% to 123.55 in 2025, then surged by 39.36% to 74.92 in 2026.
• The last three Price to Book figures came in at 74.92 (Q2 2026), 58.12 (Q1 2026), and 123.55 (Q4 2025), per Business Quant data.